Experimental and Clinical Evaluation of Two “Atromid-S” Analogues in Relation to their Differential Modes of Action

  • M. C. Stone
  • J. M. Thorp
  • J. S. Wain
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 63)


There is increasing evidence that plasma fibrinogen and some of its partial breakdown products may play a critical role in the initiation of atherosclerosis, the rheology of blood, and the availability of oxygen to the vessel wall and tissues. Pilgeram and Pickart (1) suggested that the hepatic synthesis of fibrinogen is related to the concentration of non-esterified fatty acids (FFA) in plasma. It is recognized that acute tissue damage (surgery, myocardial infarction) is followed by an increase of FFA and (later) of fibrinogen, with a sharp reduction of cholesterol-rich low-density lipoproteins (LDL).


Plasma Fibrinogen Human Albumin Hepatic Synthesis Adipose Tissue Lipolysis Lipoprotein Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pilgeram, L. O. and Pickart, L. R. J. Atheroscler. Res. 8: 155, 1968.CrossRefGoogle Scholar
  2. 2.
    Barrett, A.M. and Thorp, J. M. Br. J. Pharm. Chem. 32: 381, 1968.Google Scholar
  3. 3.
    Platt, D.S. and Thorp, J. M. Biochem. Pharmacol. 15:915, 1966.PubMedCrossRefGoogle Scholar
  4. 4.
    Thorp, J. M. and Barrett, A.M. Prog. Biochem. Pharmacol. 2: 337, 1967.Google Scholar
  5. 5.
    Barrett, A. M. Br. J. Pharm. Chem. 26: 363, 1966.Google Scholar
  6. 6.
    Thorp, J. M. In: Atherosclerosis: Proceedings of the Second International Symposium (R. J. Jones, editor), p. 541, 1970.Google Scholar
  7. 7.
    Craig, G. M. Atherosclerosis 15: 265, 1972.PubMedCrossRefGoogle Scholar
  8. 8.
    Thorp, J. M. Excerpta Medica Int. Congr. Series 254: 98, 1971.Google Scholar
  9. 9.
    Thorp, J. M. Excerpta Medica Int. Congr. Series 283: 90, 1973.Google Scholar
  10. 10.
    Hoak, J. C., Wilson, W. R., Warner, E. D., Theilem, E. O., Fry, G. L. and Benoit, F. L. J. Clin. Inv. 48:768, 1969.CrossRefGoogle Scholar
  11. 11.
    Benaim, M. E., Dewar, H. A. and Thorp, J. M. In preparation.Google Scholar
  12. 12.
    Dormandy, J. A., Gutteridge, J. M. C., Hoare, E. and Dormandy, T. L. Br. Med. J. 4:259, 1974.PubMedCrossRefGoogle Scholar
  13. 13.
    Zelis, R., Mason, D. T., Braunwald, E. and Levy, R.I. J. Clin. Inv. 49: 1007, 1970.CrossRefGoogle Scholar
  14. 14.
    Hart, A., Thorp, J. M. and Cohen, H. Postgrad. Med. J. 48: 435, 1971.Google Scholar
  15. 15.
    Hart, A., Cohen, H. and Thorp, J. M. Unpublished observations.Google Scholar
  16. 16.
    Wardle, E. N., Piercey, D. A. and Anderson, J. Postgrad. Med. J. 49: 1, 1973.PubMedCrossRefGoogle Scholar
  17. 17.
    Bottiger, L. E. and Carlson, L. A. In: Early Phases of Coronary Heart Disease-Skandia Symposia 1972. J. Waldstrom, T. Larsson, and N. Ljungstadt, editors, p. 158.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • M. C. Stone
    • 1
  • J. M. Thorp
    • 2
  • J. S. Wain
    • 2
  1. 1.Research Unit, Leigh Infirmary, Leigh, LancashireImperial Chemical Industries Ltd.Macclesfield, CheshireUK
  2. 2.Research DepartmentImperial Chemical Industries Ltd.Macclesfield, CheshireUK

Personalised recommendations